Search clinical trials for: Artemether-Lumefantrine with a single dose of 0.25mg/kg primaquine
Total 31 results
-
London School of Hygiene and Tropical MedicineRadboud University Medical Center; Centre national de recherche et de formation...CompletedMalaria | Plasmodium Falciparum | Asymptomatic MalariaBurkina Faso
-
Kilimanjaro Clinical Research InstituteLondon School of Hygiene and Tropical Medicine; Ifakara Health InstituteUnknownMalaria TransmissionTanzania
-
Wuhan Union Hospital, ChinaYichang Humanwell Pharmaceutical Co., Ltd., ChinaCompletedMechanically Ventilated PatientsChina
-
Karolinska University HospitalMuhimbili University of Health and Allied SciencesCompleted
-
Armauer Hansen Research Institute, EthiopiaUnited States Agency for International Development (USAID); Tulane University; Addis Continental Institute of Public Health and other collaboratorsUnknown
-
London School of Hygiene and Tropical MedicineCompleted
-
Fundação de Medicina Tropical Dr. Heitor Vieira...Completed
-
University Hospital, GrenobleNot yet recruitingInner Ear ; Meniere's Disease; Imaging
-
Fluart Innovative Vaccine Ltd, HungaryCompleted
-
University of Campinas, BrazilCompletedDental Caries | Dental FluorosisBrazil
-
Medical College of WisconsinCompletedAcute Myeloid LeukemiaUnited States
-
AstraZenecaCompletedHealthy Subjects | BioavailabilityGermany
-
Assistance Publique - Hôpitaux de ParisNovartisCompleted
-
AstraZenecaCompletedPharmacokinetics | Bioequivalence | Healthy Japanese SubjectsUnited Kingdom
-
Danat Al Emarat HospitalNot yet recruiting
-
National University Hospital, SingaporeCompleted
-
Shaymaa Mohammed El-AwadyRecruitingAllogenic Bone Marrow TransplantationEgypt
-
Yangzhou UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedRectal CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingB Acute Lymphoblastic Leukemia | Central Nervous System Leukemia | Testicular Leukemia | B Acute Lymphoblastic Leukemia, BCR-ABL1-LikeUnited States, Canada, Puerto Rico, Australia, New Zealand, Switzerland, Ireland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Childhood B Acute Lymphoblastic LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States, Canada, Australia, New Zealand, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI); EsPhALL Network/ BFM Study GroupRecruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | T Acute Lymphoblastic Leukemia | Mixed Phenotype Acute LeukemiaUnited States, Canada, Puerto Rico, Australia, Finland, New Zealand, Saudi Arabia, Germany, Austria, Belgium, Chile, Czechia, France, Italy, Netherlands, Sweden, Switzerland, Hong Kong, Israel
-
National Cancer Institute (NCI)Active, not recruitingT Acute Lymphoblastic Leukemia | T Lymphoblastic LymphomaUnited States, Canada, Australia, New Zealand, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Acute Undifferentiated Leukemia | Childhood T Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, New Zealand
-
National Cancer Institute (NCI)Not yet recruitingB Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Childhood B Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, New Zealand, Switzerland
-
National Cancer Institute (NCI)Active, not recruitingRecurrent B Acute Lymphoblastic LeukemiaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
National Cancer Institute (NCI)RecruitingDown Syndrome | B Acute Lymphoblastic Leukemia | B Lymphoblastic LymphomaUnited States, Canada, Puerto Rico, Australia, New Zealand